ArticleCureus2019
Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia.
Article in Cureus, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 22 citations in OpenAlex.
- Prediction model for the risk of osteoporosis incorporating factors of disease history and living habits in physical examination of population in Chongqing, Southwest China: based on artificial neural network.BMC public health · 2021Trial
- Role of Galanin system and insulin resistance parameters as predictive tools for diagnosis of Long-COVID patients.Biochemistry and biophysics reports · 2025Article
- Development and validation of an interpretable machine learning model for predicting the risk of hepatocellular carcinoma in patients with chronic hepatitis B: a case-control study.BMC gastroenterology · 2025Article
- Article
- Application of machine learning algorithms to predict osteoporosis in postmenopausal women with type 2 diabetes mellitus.Journal of endocrinological investigation · 2023Article
- A comprehensive analysis of gene expression profiling data in COVID-19 patients for discovery of specific and differential blood biomarker signatures.Scientific reports · 2023Article
- Machine learning and multi-omics data in chronic lymphocytic leukemia: the future of precision medicine?Frontiers in genetics · 2023Review
- A Dual Level Analysis with Evolutionary Computing and Swarm Models for Classification of Leukemia.BioMed research international · 2022Article
- Translational Applications of Artificial Intelligence and Machine Learning for Diagnostic Pathology in Lymphoid Neoplasms: A Comprehensive and Evolutive Analysis.Biomolecules · 2021Article
- Machine Learning Models to Predict Primary Sites of Metastatic Cervical Carcinoma From Unknown Primary.Frontiers in genetics · 2020Article
- Prediction model of artificial neural network for the risk of hyperuricemia incorporating dietary risk factors in a Chinese adult study.Food & nutrition research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Chronic lymphocytic leukemia (CLL) is one of the most common types of leukemia, and the early diagnosis of patients coincides with their proper treatment and survival. If patients are diagnosed late or proper treatment is not applied, it may lead to harmful results. Several methods could be used for the diagnosis of leukemia; some of these include complete blood count (CBC), immunophenotyping, lymph node biopsy, chest X-ray, computerized tomography (CT) scan, and ultrasound. Most of these methods are time-consuming and an application of more than one method will result as intended. This acknowledgment stresses the necessity of rapid and proper diagnosis for leukemia based on clinical and medical findings, inasmuch as it was decided to apply the artificial neural network (ANN) in order to identify a molecular biomarker for rapid leukemia diagnosis from blood samples and evaluate its potential for the detection of cancer. Materials & methods The independent sample t-test was applied with the Statistical Package for the Social Sciences (SPSS; IBM Corp, Armonk, NY, US) software on the microarray gene expression data of Gene Expression Omnibus (GEO) datasets (GSE22529); 12 genes that had shown the highest differences (among parameters whose p-value was less than 0.01) were selected for further ANN analysis. The selected genes of 53 patients were applied to the training network algorithm, with a learning rate of 0.1. Results The results showed a high accuracy of the relationship between the output of the trained network and the test data. The area under the receiver operating characteristic (ROC) curve was 0.991, which provides proof of the precision and the relationship with identifying Gelsolin as a potential biomarker for this research. Conclusions With these results, it was concluded that the training process of the ANN could be applied to rapid CLL diagnosis and finding a potential biomarker. Besides, it is suggested that this method could be performed to diagnose other forms of cancer in order to get a rapid and reliable outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.